Effective as of January 1, 2014, the board of directors of ResMed Inc. approved the appointment of Dr. Peter Farrell, current executive chairman of the board of directors, as non-executive chairman of the board. As part of the transition, Dr. Farrell will no longer be an executive officer of the company, although he will remain a non-officer employee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
183.8 USD | +0.90% |
|
-13.39% | +6.87% |
06-25 | Oppenheimer Downgrades ResMed to Market Perform From Outperform | MT |
06-24 | Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update | DJ |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.87% | 26.76B | |
+4.85% | 216B | |
+9.86% | 190B | |
+31.11% | 152B | |
+34.08% | 113B | |
+1.90% | 64.04B | |
+19.45% | 54.34B | |
+1.63% | 49.21B | |
-3.12% | 39.41B | |
+1.93% | 35.99B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- ResMed Inc. Appoints Dr. Peter Farrell as Non-Executive Chairman of the Board